MedTrace Logo

Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

NCT05050617 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-03-26

No results posted yet for this study

Summary

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism.

The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE.

The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.

Conditions

Interventions

DIAGNOSTIC_TEST

Point-of-care echocardiography

Subjects will undergo point-of-care echocardiography at the time of presentation/enrollment to assess for evidence of right sided heart dilation/strain.

Sponsors & Collaborators

  • Stony Brook University

    collaborator OTHER

  • University of California, Irvine

    collaborator OTHER

  • WellSpan Health

    lead OTHER

Principal Investigators

  • Brent A Becker, MD · WellSpan Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2025-09-30
Completion
2025-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050617 on ClinicalTrials.gov